Mark V Sherrid MD
Echocardiography, Heart Failure & Transplantation
Program Director, Hypertrophic Cardiomyopathy Program
Join to View Full Profile
425 W 59th StNew York, NY 10019
Phone+1 212-492-5550
Fax+1 212-492-5555
Dr. Sherrid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Sutter Health/California Pacific Medical CenterFellowship, Cardiovascular Disease, 1978
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1973 - 1976
Columbia University Vagelos College of Physicians and SurgeonsClass of 1973
Certifications & Licensure
CA State Medical License 1975 - Present
NY State Medical License 1974 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
Clinical Trials
Publications & Presentations
PubMed
- Cardiac MR Imaging of Flow Abnormalities in Hypertrophic Cardiomyopathy Phenotypes.Kana Fujikura, Mark V Sherrid, Daniele Massera, Leon Axel
Magnetic Resonance Imaging Clinics of North America. 2026-05-01 - The Physiology of Flow Cessation: A Call for Inclusion of Continuous-Wave Doppler Interrogation of the Mid-apical Left Ventricle in the Standard Hypertrophic Cardiomyo...Daniele Massera, Mark V Sherrid
Journal of the American Society of Echocardiography. 2026-04-09 - 1 citationsIncidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.Olives Nguyen, Jack Wiedrick, Daniele Massera, Elizabeth Adlestein, Sumar Frejat
Journal of Cardiac Failure. 2026-03-01
Journal Articles
- Myocardial Energy Depletion and Dynamic Systolic Dysfunction in Hypertrophic CardiomyopathyMark Sherrid, MD, Nature
Press Mentions
Talking Out About Women’s ‘Silent Killer’February 1st, 2019
Most States Don't Require AEDs in SchoolsMarch 27th, 2017
Few States Require AEDs in SchoolsMarch 27th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
